Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) is designed to be injected into the layer of fat just beneath the skin, not into muscle. If the needle reaches muscle tissue, the medicine is likely to be absorbed faster than intended, and the injection is more likely to hurt. Most accidental muscle injections are a one-off, not a crisis — but understanding why subcutaneous tissue is the correct target makes a real difference to comfort and consistency. As a prescription-only medicine, Wegovy is supplied with injection guidance and a Patient Information Leaflet; your prescriber and pharmacist are the right people to turn to if you have concerns about technique.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people assume the guidance to inject into fat rather than muscle is there to spare you discomfort, and that hitting the muscle occasionally doesn't really matter. It's an understandable conclusion — the needle is short, the sites feel similar, and if nothing obviously went wrong after one injection, the reasoning is that the location must not matter much. That assumption is worth setting down gently, because it does matter, just not for the reason most people fear.
The reason subcutaneous (under-skin) injection is specified isn't simply pain management. Wegovy was studied and licensed based on a subcutaneous delivery route, which gives the medicine a predictable, gradual absorption profile. Intramuscular absorption is generally faster, meaning the semaglutide reaches your bloodstream more quickly than the formulation was designed for. Whether that changes clinical outcomes in a one-off situation is unlikely, but consistency across your weekly doses matters for how well the treatment works over months. The NHS patient information on semaglutide is clear that the subcutaneous route is the correct one; this isn't advisory padding.
If you're unsure whether a past injection landed where it should have, our page on what happens if you inject Wegovy into a muscle is covered in more detail alongside what typically happens next.
Muscle tissue has a denser blood supply and more nerve endings than the subcutaneous layer. An injection that reaches muscle tends to produce a sharper, deeper ache that lingers for longer than the brief sting of a correctly placed subcutaneous dose. Bruising is more common too. These sensations are useful feedback: if your injections are consistently more painful than you'd expect, technique or site is the thing to review, not the medicine itself.
The most common cause of accidental intramuscular injection is using too much force rather than a slow, steady press, or choosing a site without enough subcutaneous fat. Thinner individuals, or those injecting into the upper arm without assistance, are at slightly higher risk. Pinching a fold of skin before injecting (and keeping that pinch held until after the needle is withdrawn) lifts subcutaneous tissue away from the muscle beneath. It's a small step that makes a measurable difference, and if you want to understand more about what goes wrong when that tissue separation is missed, our guide to what it means to have injected Wegovy into muscle explains the mechanics in plain terms. The technique for thigh injections includes specific guidance on pinch depth for that site.
Needle length plays a role as well. The Wegovy pen uses a fixed, short needle designed for subcutaneous delivery. Using replacement needles of the correct specification matters; compatible replacement needles are available if you need to restock between orders.
Wegovy can be injected into the abdomen (at least a few centimetres from the navel), the outer thigh, or the upper arm. Each site has a different depth of subcutaneous fat, which affects how easily a subcutaneous injection stays subcutaneous. The abdomen generally offers the most accessible fat layer for most people and is the site with the least risk of accidentally going too deep. The outer thigh is a reliable second choice. The upper arm is the trickiest site to self-inject correctly, partly because it can be harder to pinch the tissue without assistance and partly because the subcutaneous layer there is thinner in some people.
Rotating injection sites each week prevents the localised skin changes (lipodystrophy, lumps, or hardened patches) that develop if the same spot is used repeatedly. These changes affect absorption unpredictably, which is another route by which consistent technique influences consistent results. Cleaning the skin with an alcohol swab before each injection and allowing it to dry keeps the site ready; alcohol swabs are straightforward to source if you're running low.
For detail on arm-specific considerations, see the page covering injecting Wegovy into the arm.
A single injection that landed in muscle is unlikely to cause lasting harm. You may notice more soreness, a deeper ache, or a bruise over the following day or two. These typically settle without intervention. What warrants a call to your prescriber or pharmacist is anything beyond that expected soreness: significant swelling, redness spreading from the site, warmth that doesn't ease, or pain that worsens rather than improves over several days. These signs could point to an injection-site reaction worth assessing.
If you have had a string of painful injections and aren't sure whether your technique is correct, this is exactly the kind of question the team at a service like a clinician-led pharmacy can help with, it's the sort of thing our prescribers hear regularly and is always worth raising rather than pushing through. Guidance on the full range of what to expect and what to do after an accidental intramuscular injection covers the more specific scenarios in one place.
The MHRA Yellow Card scheme lets you report any unexpected side effects, including injection-site reactions, and contributes to ongoing safety monitoring of medicines like Wegovy.
If you haven't yet started treatment and are weighing up whether injectable or oral options suit you better, our guide to weight loss injections including Ozempic is a useful place to compare your options before booking the free consultation with our prescribers, no commitment, and a clinician reads your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.